<table id="table16" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 16: The Effect of Concomitant Medications that Affect the Gastric pH and Gastric Motility on the Pharmacokinetics of Posaconazole Delayed-Release Tablets in Healthy Volunteers</caption>
<col align="left" valign="middle" width="35%"></col>
<col align="center" valign="middle" width="25%"></col>
<col align="center" valign="middle" width="20%"></col>
<col align="center" valign="middle" width="20%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule" valign="bottom">Coadministered Drug</th>
<th stylecode="Rrule" valign="bottom">Administration Arms</th>
<th stylecode="Rrule" valign="bottom">Change in C<sub>max</sub>
<br/>(ratio estimate<footnote id="t15f1">Ratio Estimate is the ratio of coadministered drug plus posaconazole to posaconazole alone for C<sub>max</sub> or AUC<content stylecode="bold">
<sub>0-last</sub>.</content>
</footnote>;<br/>90% CI of the ratio estimate)</th>
<th stylecode="Rrule" valign="bottom">Change in AUC<sub>0-last</sub>
<br/>(ratio estimate<footnoteref idref="t15f1"></footnoteref>;<br/>90% CI of the ratio estimate)</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Mylanta<sup>®</sup> Ultimate strength liquid (Increase in gastric pH)</td>
<td stylecode="Rrule">25.4 meq/5 mL, 20 mL</td>
<td stylecode="Rrule">↑6%<br/>(1.06; 0.90 -1.26)↑</td>
<td stylecode="Rrule">↑4%<br/>(1.04; 0.90 -1.20)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ranitidine (Zantac<sup>®</sup>) (Alteration in gastric pH)</td>
<td stylecode="Rrule">150 mg (morning dose of 150 mg Ranitidine BID)</td>
<td stylecode="Rrule">↑4%<br/>(1.04; 0.88 -1.23)↑</td>
<td stylecode="Rrule">↓3%<br/>(0.97; 0.84 -1.12)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Esomeprazole (Nexium<sup>®</sup>) (Increase in gastric pH)</td>
<td stylecode="Rrule">40 mg (QAM 5 days, day -4 to 1)</td>
<td stylecode="Rrule">↑2%<br/>(1.02; 0.88-1.17)↑</td>
<td stylecode="Rrule">↑5%<br/>(1.05; 0.89 -1.24)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Metoclopramide (Reglan<sup>®</sup>) (Increase in gastric motility)</td>
<td stylecode="Rrule">15 mg four times daily during 2 days (Day -1 and 1)</td>
<td stylecode="Rrule">↓14%<br/>(0.86, 0.73,1.02)</td>
<td stylecode="Rrule">↓7%<br/>(0.93, 0.803,1.07)</td>
</tr>
</tbody>
</table>